Attached files
file | filename |
---|---|
10-K - 10-K - Wright Medical Group N.V. | d845440d10k.htm |
EX-21.1 - EX-21.1 - Wright Medical Group N.V. | d845440dex211.htm |
EX-23.1 - EX-23.1 - Wright Medical Group N.V. | d845440dex231.htm |
EX-10.5 - EX-10.5 - Wright Medical Group N.V. | d845440dex105.htm |
EX-32.1 - EX-32.1 - Wright Medical Group N.V. | d845440dex321.htm |
EX-10.6 - EX-10.6 - Wright Medical Group N.V. | d845440dex106.htm |
EX-32.2 - EX-32.2 - Wright Medical Group N.V. | d845440dex322.htm |
EX-10.7 - EX-10.7 - Wright Medical Group N.V. | d845440dex107.htm |
EX-31.1 - EX-31.1 - Wright Medical Group N.V. | d845440dex311.htm |
EX-31.2 - EX-31.2 - Wright Medical Group N.V. | d845440dex312.htm |
EX-10.18 - EX-10.18 - Wright Medical Group N.V. | d845440dex1018.htm |
EX-10.17 - EX-10.17 - Wright Medical Group N.V. | d845440dex1017.htm |
EXCEL - IDEA: XBRL DOCUMENT - Wright Medical Group N.V. | Financial_Report.xls |
Exhibit 12.1
STATEMENT OF COMPUTATION OF RATIOS
RATIO OF EARNINGS TO FIXED CHARGES
The following table sets forth our ratios of earnings to fixed charges on a historical basis for each of the periods presented. Our net losses were insufficient to cover fixed charges in each of the periods presented. Because of these deficiencies, the ratio information is not applicable for such periods.
Year ended | ||||||||||||||||||||
December 28, 2014 |
December 29, 2013 |
December 30, 2012 |
January 1, 2012 |
January 2, 2011 |
||||||||||||||||
Ratio of earnings to fixed charges(1) |
$ | | $ | | $ | | $ | | $ | |
(1) | For the years ended December 28, 2014, December 29, 2013, December 30, 2012, January 1, 2012, and January 2, 2011 we had no earnings and, therefore, are unable to calculate the ratio of fixed charges to earnings. Our earnings for these periods were insufficient to cover fixed charges by $36.4 million, $43.0 million, $37.8 million, $44.4 million, and $67.5 million, respectively. The ratio of earnings to fixed charges and preferred stock dividends is the same as the ratio of earnings to fixed charges for the periods presented because no shares of preferred stock were outstanding during these periods. |